For Clinicians

Clinician Benefits

Safe & Effective

  • No thermal damage (unlike laser or Rf), therefore
    no thermal risks
  • Proven sclerosants, combined with mechanical
    agitation give excellent results

 

 Minimal Steps

  • No need for tumescent anaesthetic
  • Superior ergonomics – combination infusion catheter /
    guide wire removes need for guide wire / dilator /catheter exchanges
  • Steerable guide wire enhances access capability

 

 Excellent Results

  • Precision longitudional and radial drug delivery to the
    specific treatment areas ensuring maximum results
  • Ensures results far beyond what a sclerosant alone
    can achieve

 

 High Patient Acceptance

  • No Pain
  • Minimal discomfort
  • Minimal bruising
  • Reduced risks
  • Quick return to normal activities

 

Reduced Barriers to Use

  • Great flexibility in terms of where the procedure can be done.
  • No capital equipment expenditure or maintenance costs.

Download Presentation from
American College of Phlebology (ACP)
November 2010

MechanoChemical Endovenous Ablation:
Final Results of First Clinical Trial

Steve Elias MD FACS FACPh
Director, Centers for Vein Disease
Mount Sinai NY and Englewood NJ Hospitals
Associate Professor of Surgery
Mount Sinai School of Medicine, NY

Click to download PDF file

Clinician Video

Steven Elias, MD FACS FACPh
ClariVein Principal investigator
Director Centers for Vein Disease

Englewood Hospital and Medical Center, NJ

Mount Sinai Hospital, NY
Associate Professor of Surgery

Mount Sinai Hospital, NY